Pierluigi Carratù1, Valentina Anna Ventura2, Mauro Maniscalco3, Silvano Dragonieri2, Simona Berardi4, Roberto Ria4, Vitaliano Nicola Quaranta2, Angelo Vacca4, Fiorella Devito5, Marco Matteo Ciccone5, Barbara Anne Phillips6, Onofrio Resta2. 1. Institute of Respiratory Disease, School of Medicine, University of Bari, Piazza G. Cesare 12, 70122, Bari, Italy. pierluigicarratu@yahoo.com. 2. Institute of Respiratory Disease, School of Medicine, University of Bari, Piazza G. Cesare 12, 70122, Bari, Italy. 3. Section of Respiratory Medicine, Hospital S Maria della Pietà, Casoria, Naples, Italy. 4. Division of Internal Medicine, University of Medicine, Bari, Italy. 5. Institute of Cardiovascular Disease, University of Medicine, Bari, Italy. 6. Division of Pulmonary, Critical Care and Sleep Medicine, University of Kentucky, Lexington, KY, 40508, USA.
Abstract
OBJECTIVE: Obstructive sleep apnea (OSA) and obesity are increasingly prevalent worldwide. Both promote endothelial dysfunction contributing to systemic and pulmonary hypertension over time. Endothelin-1 (ET-1) plays a pivotal role in the development of pulmonary hypertension (PH). The aim of the present study was to assess the association between plasma ET-1 and echocardiographic findings in obese individuals with and without OSA, as well as in non-obese patients with OSA. METHODS: Ninety-seven subjects (56 males) were enrolled in the study. All subjects underwent the following tests: venous endothelin-1 levels, pulmonary function testing, and arterial blood gas analysis. All patients except controls underwent transthoracic echocardiography and portable testing for sleep-disordered breathing. RESULTS: Plasma ET-1 levels were significantly higher in obese patients, both with and without OSA (respectively, n = 30 (mean value, 268.06 ± 49.56 pg/ml) and n = 32 (mean value, 263.12 ± 65.26 pg/ml)), compared with non-obese patients with OSA or to healthy controls (respectively, n = 20 (mean value, 149.8 ± 23.09 pg/ml) and n = 15 (mean value, 152.3 ± 27.64 pg/ml); p < 0.0001). Pulmonary artery pressure (PAPs) in obese patients with OSA were significantly higher than in obese patients without OSA (p < 0.0001), while there was no statistical difference between PAPs of obese patients without OSA, compared with the group of non-obese OSA patients. Plasma ET-1 levels significantly correlated with systolic PAPs in obese patients both with and without OSA (respectively, n = 30, r = 0.385, p = 0.03567; n = 32, r = 0.3497, p = 0.0497). CONCLUSIONS: Our study suggests that endothelin levels are more strongly associated with weight than the presence of sleep-disordered breathing, but pulmonary artery hypertension is associated with both weight and OSA.
OBJECTIVE:Obstructive sleep apnea (OSA) and obesity are increasingly prevalent worldwide. Both promote endothelial dysfunction contributing to systemic and pulmonary hypertension over time. Endothelin-1 (ET-1) plays a pivotal role in the development of pulmonary hypertension (PH). The aim of the present study was to assess the association between plasma ET-1 and echocardiographic findings in obese individuals with and without OSA, as well as in non-obesepatients with OSA. METHODS: Ninety-seven subjects (56 males) were enrolled in the study. All subjects underwent the following tests: venous endothelin-1 levels, pulmonary function testing, and arterial blood gas analysis. All patients except controls underwent transthoracic echocardiography and portable testing for sleep-disordered breathing. RESULTS: Plasma ET-1 levels were significantly higher in obesepatients, both with and without OSA (respectively, n = 30 (mean value, 268.06 ± 49.56 pg/ml) and n = 32 (mean value, 263.12 ± 65.26 pg/ml)), compared with non-obesepatients with OSA or to healthy controls (respectively, n = 20 (mean value, 149.8 ± 23.09 pg/ml) and n = 15 (mean value, 152.3 ± 27.64 pg/ml); p < 0.0001). Pulmonary artery pressure (PAPs) in obesepatients with OSA were significantly higher than in obesepatients without OSA (p < 0.0001), while there was no statistical difference between PAPs of obesepatients without OSA, compared with the group of non-obese OSA patients. Plasma ET-1 levels significantly correlated with systolic PAPs in obesepatients both with and without OSA (respectively, n = 30, r = 0.385, p = 0.03567; n = 32, r = 0.3497, p = 0.0497). CONCLUSIONS: Our study suggests that endothelin levels are more strongly associated with weight than the presence of sleep-disordered breathing, but pulmonary artery hypertension is associated with both weight and OSA.
Authors: R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle Journal: Eur Respir J Date: 2008-12-01 Impact factor: 16.671
Authors: Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza Journal: J Am Coll Cardiol Date: 2009-06-30 Impact factor: 24.094
Authors: J K Friedman; C H Nitta; K M Henderson; S J Codianni; L Sanchez; J M Ramiro-Diaz; T A Howard; W Giermakowska; N L Kanagy; L V Gonzalez Bosc Journal: Vascul Pharmacol Date: 2013-11-15 Impact factor: 5.773
Authors: Omar A Minai; Basma Ricaurte; Roop Kaw; Jeff Hammel; Mary Mansour; Kevin McCarthy; Joseph A Golish; James K Stoller Journal: Am J Cardiol Date: 2009-11-01 Impact factor: 2.778